Pregabalin for Chronic Pelvic Pain in Women

NCT ID
NCT07818577
Registry status
Not yet recruiting
Study type
Interventional
Phase
Not applicable
Sponsor
Beijing Tiantan Hospital
Conditions
Chronic Pelvic Pain, Chronic Pelvic Pain Syndrome

Overview

ClinicalTrials.gov lists this study as Not yet recruiting.

Official title: Pregabalin for Chronic Pelvic Pain in Women: Study Protocol for a Randomized, Prospective, Multicenter, Open Label-controlled Trial

Enrollment: 308 participants (Estimated).

What is being studied

  • Intervention: Acids, Acyclic
  • Intervention: Amino Acids
  • Intervention: Amino Acids, Peptides, and Proteins
  • Intervention: Aminobutyrates
  • Intervention: Behavior Therapy
  • Intervention: Behavioral Disciplines and Activities
  • Behavioral: Behavioral Treatment
  • Intervention: Butyrates
  • Intervention: Carboxylic Acids
  • Intervention: gamma-Aminobutyric Acid
  • Intervention: Organic Chemicals
  • Drug: Pregabalin
  • Intervention: Pregabalin
  • Intervention: Psychotherapy

Who may be eligible

Ages
18 Years to 65 Years
Sex
Female
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * Women aged 18-65 years. * Diagnosis of chronic pelvic pain based on the 2022 revisions to the European Association of Urology criteria. * Use of, or willingness to use, effective contraception to avoid pregnancy during the study period. * Moderate to severe chronic pelvic pain lasting more than 6 months. Moderate pain is defined as a VAS score of 4-6, and severe pain as a VAS score of 7 or higher. * Sufficient cognitive and language skills to comply with all study requirements. Exclusion Criteria: * Dysmenorrhea as the sole pain complaint. * History of malignancy. * Current or previous use of pregabalin. * Planned surgery within the next 6 months. * Contraindication to pregabalin or a previous adverse reaction to pregabalin. * Current use of gonadotropin-releasing hormone agonists with inability or unwillingness to discontinue treatment. * Pregnancy, breastfeeding, or intention to become pregnant within the next 6 months.

Study locations

No study locations are listed in the registry data.

Study details

Start date
October 1, 2026
Primary completion date
June 1, 2027
Completion date
December 1, 2027
First posted
September 14, 2026

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07818577
Registry last updated
September 16, 2026
QualifiedStudies registry data refreshed
September 28, 2026
QualifiedStudies record fetched
September 28, 2026

View NCT07818577 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Chronic Pain studies | Clinical trial FAQ